Noninvasive Respiratory Support

Deis, Jamie N.; Abramo, Thomas J.; Crawley, Lee

doi:10.1097/pec.0b013e31816ffbe8

Cited by 20 publications

(13 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Numerous experiences have been reported in studies showing the feasibility and lack of complications using CPAP to treat ACPE in out-of-hospital emergencies,11,174,175 with improvement in short-term outcomes 175…”

Section: Where To Apply Nivmentioning

confidence: 99%

“…A recent survey carried out in USA showed that the use of NIV to treat acute exacerbations of chronic obstructive pulmonary disease (COPD) increased more than 400% in one decade (from 1% in 1998 to 4.5% in 2008) and was associated with a 42% reduction in IMV 7. NIV is now a first-line therapy in emergency departments,8 regular hospital wards,9 palliative10 or pediatric11 care units, and even in out-of-hospital patients 12,13…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Noninvasive ventilation in acute respiratory failure

Mas¹,

Masip²

2014

COPD

View full text Add to dashboard Cite

After the institution of positive-pressure ventilation, the use of noninvasive ventilation (NIV) through an interface substantially increased. The first technique was continuous positive airway pressure; but, after the introduction of pressure support ventilation at the end of the 20th century, this became the main modality. Both techniques, and some others that have been recently introduced and which integrate some technological innovations, have extensively demonstrated a faster improvement of acute respiratory failure in different patient populations, avoiding endotracheal intubation and facilitating the release of conventional invasive mechanical ventilation. In acute settings, NIV is currently the first-line treatment for moderate-to-severe chronic obstructive pulmonary disease exacerbation as well as for acute cardiogenic pulmonary edema and should be considered in immunocompromised patients with acute respiratory insufficiency, in difficult weaning, and in the prevention of postextubation failure. Alternatively, it can also be used in the postoperative period and in cases of pneumonia and asthma or as a palliative treatment. NIV is currently used in a wide range of acute settings, such as critical care and emergency departments, hospital wards, palliative or pediatric units, and in pre-hospital care. It is also used as a home care therapy in patients with chronic pulmonary or sleep disorders. The appropriate selection of patients and the adaptation to the technique are the keys to success. This review essentially analyzes the evidence of benefits of NIV in different populations with acute respiratory failure and describes the main modalities, new devices, and some practical aspects of the use of this technique.

show abstract

Section: Where To Apply Nivmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Noninvasive ventilation in acute respiratory failure

Mas¹,

Masip²

2014

COPD

View full text Add to dashboard Cite

show abstract

“…NIV techniques have developed over the last 80 years and have been increasingly refined in the last 20 years since their use begun in obstructive sleep apnoea and related conditions [5]. The use of NIV in adult critical care patients has shown benefits when compared to intubation or venturi mask in terms of mortality, reduced length of stay, reduced ventilator-associated pneumonia and associated cost savings [6][7][8].…”

Section: Introductionmentioning

confidence: 99%

Increase in use of non-invasive ventilation for infants with severe bronchiolitis is associated with decline in intubation rates over a decade

et al. 2012

View full text Add to dashboard Cite

show abstract

“…BiPAP provides respiratory support by unloading the diaphragm and accessory muscles, increasing tidal volume and minute ventilation, opening obstructed or collapsed alveoli, and decreasing the frequency of occlusive apnea and hypopnea [15,16]. Effective administration of BiPAP requires a well-fitted mask, optimal patient-ventilator synchrony (i.e., appropriate patient mental status and cooperation), and well-trained pediatric respiratory therapists to continuously monitor the circuit.…”

Section: Introductionmentioning

confidence: 99%

“…However, use of BiPAP as a beneficial treatment modality for acute severe asthma exacerbations in children is becoming more widely described and accepted in children of all weights [6][7][8][9][10][11][12][13][14][15][16][17][18][19]. The purpose of this study is to assess and report the safety of BiPAP use with traditional therapies for the treatment of acute severe asthma exacerbations in children who weigh 20 kg or less in the PED population.…”

Section: Introductionmentioning

confidence: 99%